Objective:
Develop a combined vaccine and biosimilar strategy for a start-up drug company.
Activities:
- Identify pipeline candidates
- Research a marketing and reimbursement strategy
- Support the development of an initial regulatory strategy
- Initiated discussions for the in-licensing of molecules
Deliverables:
- Various financial models
- A manufacturing strategy
- A marketing and reimbursement strategy
Result:
A recommendation that the in-licensing models proposed along with the unique market and reimbursement dynamics made the business a higher risk than client originally anticipated. Client elected not to pursue the model further.
